14-day Premium Trial Subscription Try For FreeTry Free
NYSE:RNN
Delisted

Rexahn Pharmaceuticals, Inc. Stock Forecast

$5.24
+0 (+0%)
At Close: Sep 19, 2019
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Rexahn Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Rexahn Pharmaceuticals, Inc. is RNN and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Rexahn Pharmaceuticals, Inc. Stock?
Rexahn Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Rexahn Pharmaceuticals, Inc. Stock?
Rexahn Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rexahn Pharmaceuticals, Inc. Stock.

What's the current price of Rexahn Pharmaceuticals, Inc. Stock?
As of the end of day on the Sep 19, 2019, the price of an Rexahn Pharmaceuticals, Inc. (RNN) share was $5.24.

What is the 52-week high and low for Rexahn Pharmaceuticals, Inc. Stock?
The 52-week high for Rexahn Pharmaceuticals, Inc. Stock is $9.18 and the 52-week low is $0.430.
Click to get the best stock tips daily for free!

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes treatments for cancer. The company’s clinical stage oncology candidates include Archexin that completed a pilot Phase IIa clinical trial for the treatment of pancreatic cancer; RX-3117, which is in Phase Ib clinical trial for the treatment of patients with solid tumors; and Supinoxin that is in Phase I clinical trial for patients wit... RNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT